Search results

The Faculty of Medicine research and travel grantsTwo calls per year, see deadlines for submission on their website.The Swedish Parkinson FoundationTwo calls per year, see deadlines for submission on their website.The Royal Physiographic Society in LundSee deadlines for submission on their website.Wenner-Gren StiftelsernaTwo calls per year, see deadlines for submission on their website.Search for

https://www.multipark.lu.se/other-sources-funding-travel-grants - 2025-12-13

The “In vivo Brain Circuit Analysis” platform is a research infrastructure devoted to integrating methods and techniques to interrogate neuronal circuits in health and disease using advanced methods for the perturbation and recording of cell activity. If you are interested in using the platform contact: andreas.heuer@med.lu.se Currently we have the following equipment available for users:1) Equipt

https://www.multipark.lu.se/infrastructures/vivo-brain-circuit-analysis - 2025-12-13

Our overarching research goal is to create new and innovative strategies for improved and novel treatments, disease modifications and eventually cures for neurodegenerative diseases. We are striving to understand the mechanisms of neurodegenerative diseases, and to create a dynamic structure for the advancement of research, innovation and education in the field. Ultimately, our research will impro

https://www.multipark.lu.se/research - 2025-12-13

Welcome to the Microscopy Platform! This platform consists of four systems under one umbrella platform.Below is an overview of the systems included in this platform as well as links to their webpages with more information:SystemTarget purposeLocationImaris SingleFull with Clearview version 10.2 (Workstation)3D/4D image visualization and analysisBMC B1155Leica SP8 laser scanning confocal microscope

https://www.multipark.lu.se/infrastructures/microscopy-platform - 2025-12-13

Now available within MultiPark is a Zeiss Axio Imager M2 system, which has been brought into the environment with the intention of serving as a large image acquisition system. It is capable of bright-field and fluorescence illumination.The microscope is an upright system with a motorized stage, capable of taking both large, stitched images and Z-stacks. It is also equipped with a Zeiss ApoTome 2,

https://www.multipark.lu.se/infrastructures/microscopy-platform/zeiss-axio-imager-m2 - 2025-12-13

Course title: VMFP09 Advanced Neuroscience (30 credits)Course language: EnglishCourse venue: Lund University Medical Faculty, Biomedical Centre (BMC), Sölvegatan 19, Lund, Sweden.Course aim:  The aim of the course is to acquire in-depth theoretical and practical knowledge in the subject of neuroscience, from basic neuroscientific concepts to preclinical and clinical applications. In addition, the

https://www.multipark.lu.se/lund-university-lu-neuroscience-graduate-school/advanced-neuroscience-course - 2025-12-13

A multidisciplinary course on health focusing on Alzheimer’s disease and Parkinson’s disease Lund University is part of The European University Alliance for Global Health (EUGLOH), which is a strategic partnership between nine universities in the context of the European Commission’s European Universities Initiative. During the first study period (26 Jan 2026 - 20 Mar 2026) of the spring semester 2

https://www.multipark.lu.se/lund-university-lu-neuroscience-graduate-school/eugloh-winter-course - 2025-12-13

This group focuses on unravelling the role of neuroinflammation in neurodegenerative diseases, to better understand disease progression and to find new strategies for better treatments. Neuroinflammation, orchestrated by activated glial cells, plays a significant role in neurodegenerative disorders. However, it is still not clear whether neuroinflammation contributes to or is a result of neuropath

https://www.multipark.lu.se/neuroinflammatory-pathways-neurodegenerative-diseases-0 - 2025-12-13

This SIG targets digital tools that measures cognitive and motor symptoms in Alzheimer´s disease and Parkinson’s disease. We are specifically interested in their diagnostic and prognostic values, the ability to track disease progression and to detect effects of interventional studies as well as their implementation in clinical practice. In alignment with MultiPark's strategic goalsUnderstand the o

https://www.multipark.lu.se/digital-tools-reliably-evaluate-cognitive-and-neurological-symptoms - 2025-12-13

This group focuses on investigating the potential of reprogramming cells for modeling and cell replacement therapies in neurodegenerative disorders. We use cellular reprogramming to convert resident brain cells, such as glia, into neurons in the living brain. With a similar method, we may also convert somatic cells directly into other cell types such as neurons, astrocytes and oligodendrocytes, fo

https://www.multipark.lu.se/cellular-reprogramming-neurodegenerative-disease-modeling-diagnostics-and-repair - 2025-12-13

This group focuses on fostering translational pharmacological projects, all the way from an initial discovery in experimental models to clinical studies. This special interest group gathers researchers using and developing pharmacological tools to understand and treat neurodegenerative diseases and neurodegeneration following acute conditions like ischemic stroke and traumatic brain injuries. We c

https://www.multipark.lu.se/regenerative-pharmacology - 2025-12-13

Multidisciplinary neuroresearch on Parkinson’s and Alzheimer’s disease How we aim to understand, treat, and cure Over 40 research groups with complementary expertise Our core comprises experimental, clinical, and health science researchers Special interest groups, from molecule to patient Senior and junior researchers meet for scientific discussions and to envision new collaborative initiatives So

https://www.multipark.lu.se/multipark - 2025-12-13

Multidisciplinary Neuroresearch on Parkinson´s and Alzheimer´s Multidisciplinary research on neurodegenerative diseases and related brain disorders with the aim to better understand, treat, and cure. Our rootsMultiPark means “Multidisciplinary research focused on Parkinson´s disease” Building on a tradition of excellence in dopamine research at Lund University, MultiPark originally focused exclusi

https://www.multipark.lu.se/about-multipark-future-page-2025 - 2025-12-13

Our researchÅsa Mackenzie’s research group has as goal to solve the internal organization of the subthalamic area with the purpose to decode neurobiological underpinnings of emotion. Despite their impact on well-being, affective symptoms of Parkinson’s disease, including anxiety, apathy and depression, have remained under-investigated. The underlying anatomy and neurocircuitry remain to be fully e

https://www.multipark.lu.se/molecular-neuroanatomy - 2025-12-13

Multidisciplinary research on neurodegenerative diseases Multidisciplinary research on neurodegenerative diseases and related brain disorders with the aim to better understand, treat, and cure. A strategic research area with pioneering rootsMultiPark is a strategic research area supported by the Swedish Government since 2010.We aim to unravel basic disease mechanisms, improve diagnostic and progno

https://www.multipark.lu.se/about-multipark - 2025-12-13

Donna Wilcock, Indiana University School of Medicine, USAThomas Perlmann, Karolinska Institutet, StockholmMarina Romero-Ramos, Aarhus University, DenmarkBart De Strooper, KU Leuven, Belgium, and University College London, EnglandGünther Deuschl, Christian-Albrechts-University Kiel, GermanyDavid Devos, Medical Pharmacology CHU, University of Lille, INSERM U1172Li-Huei Tsai, Massachusetts Institute

https://www.multipark.lu.se/frontiers-neuroscience-seminar-series/previous-frontiers-neuroscience-talks - 2025-12-13

How MultiPark research creates value for society Our research is of high societal relevance. Living with a progressive neurodegenerative disease has detrimental effects for the individual and next of kins, including inducing major societal challenges. Moreover, major neurocognitive disorders (“dementia”) are considered a global health challenge and priority.  Our goal is to early detect those at r

https://www.multipark.lu.se/societal-impact - 2025-12-13

Evidence-based clinical guidelinesOur senior researchers contribute to the development of national and international evidence-based (GRADE) clinical guidelines since 2014, advancing standards of care across the field. Below are some examples:Parkinson-Krankheit: Leitlinien fur Diagnostik und Therapie in der Neurologie.German evidence-based guidelines for Parkinson´s disease (Evidence-grade: S2k).

https://www.multipark.lu.se/clinical-guidelines - 2025-12-13

PROGRAM FOR 202524 April, 16:00, Segerfalk lecture hall, BMC A10Professor Bill Seeley, UCSF Memory and Aging Center, USALecture title: "Upstream pathogenesis in FTD/ALS"Lecture host: Alexander Santillo Bio-sketch:Professor Seeley is a behavioral neurologist who specializes in neurodegenerative dementia. His lab has taken a leading role in identifying the neuron types, brain regions, and large-scal

https://www.multipark.lu.se/frontiers-neuroscience-seminar-series - 2025-12-13

MultiPark researchers contribute to international recommendations regarding diagnostics, prognostics, and treatments of neurodegenerative disorders. Below are some examples. 2025The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study.Ashton NJ, Keshavan A, Brum WS, Andreasson U, Arslan B, Droescher M, Barghorn S, Vanbrabant J, Lambrechts

https://www.multipark.lu.se/international-recommendations - 2025-12-13